Early research (Phase 1)Study completedNCT00681798What this trial is testingDose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas CarcinomaWho this might be right forPancreatic Cancer Sanofi 8
Not applicableStudy completedNCT07497204What this trial is testingSplenic Artery Infusion Chemotherapy vs Systemic Chemotherapy in Advanced Pancreatic Body/Tail CancerWho this might be right forPancreatic Cancer (Unresectable) Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Looking for participantsNCT05053971What this trial is testingTesting A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+6 more National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Ended earlyNCT01693276What this trial is testingGemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic CancerWho this might be right forPancreatic Cancer Olugbenga Olowokure 3
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00383760What this trial is testingEribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer PatientsWho this might be right forAdenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Early research (Phase 1)Looking for participantsNCT06278454What this trial is testingSafety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node MetastasesWho this might be right forUnresectable Pancreatic CancerAdvanced Pancreatic CancerLymph Node Metastases Chengdu New Radiomedicine Technology Co. LTD. 58
Testing effectiveness (Phase 2)Ended earlyNCT03585062What this trial is testingTrial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic CancerWho this might be right forPancreatic CancerNeoadjuvant Chemotherapy Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642What this trial is testingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Who this might be right forUterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more GV20 Therapeutics 227
Testing effectiveness (Phase 2)Looking for participantsNCT05706129What this trial is testingAssess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more Lumara Bio Oncologics GmbH 270
Early research (Phase 1)Study completedNCT04672434What this trial is testingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 48
Early research (Phase 1)Study completedNCT01783171What this trial is testingDinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryWho this might be right forPancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer AJCC v6 and v7+2 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT04156087What this trial is testingProgression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Non-resectable Baki Topal 12
Early research (Phase 1)Not Yet RecruitingNCT07555587What this trial is testingSafety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)Who this might be right forUnresectable Locally Advanced Pancreatic Carcinoma NRT MedTech Australia Pty Ltd 10
Early research (Phase 1)Study completedNCT00008099What this trial is testingVaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic CancerWho this might be right forPancreatic Cancer University of Pittsburgh 25
Testing effectiveness (Phase 2)Ended earlyNCT01359007What this trial is testingFOLFIRINOX in Patients With Inoperable Pancreatic CancerWho this might be right forAdenocarcinoma of Pancreas University of Oklahoma 5
Testing effectiveness (Phase 2)UnknownNCT02737228What this trial is testingStudy of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerWho this might be right forPancreatic Neoplasms CrystalGenomics, Inc. 24
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75